exiting during each turnover. This property of the antiport enables Mrp to achieve accumulation of cytoplasmic H + against their concentration gradient (4-5). The coupled Na + efflux activity of the antiporters supports Na + -resistance and produces an inwardly directed gradient of Na + that drives solute transport and flagellar rotation in alkaliphilic bacteria (6) (7) (8) (9) . Although extremely alkaliphilic Bacillus species contain multiple cation/proton antiporters (1, 10) , the Mrp-type antiporter has a dominant and essential role in alkaliphily (11) (12) . Mrp antiporters are also broadly distributed among non-alkaliphilic Gram-positive and Gram-negative bacteria and play roles in diverse physiological processes that may depend upon pH and Na + homeostasis (2) . In addition to Na + /H + antiport, several of these Mrp antiporters support resistance to anions such as arsenite and bile salts (13-15). We hypothesize that Mrp complexes are consortiums of more than one transporter type (2) .
The most intensively studied Mrp systems have seven (MrpA-to-MrpG) or six (a fused MrpA/B-to-MrpG) hydrophobic proteins that are encoded in operons (2, 10, (16) (17) , in contrast to most other bacterial Na 2 proteins are required for Na + /H + antiport activity (20-21). Our group subsequently expressed the mrp operon from alkaliphilic Bacillus pseudofirmus OF4 in antiporter-deficient E. coli strain KNabc after engineering the operon so that each of the seven Mrp proteins could be detected using antibody probes. We identified hetero-oligomeric Mrp complexes that corresponded to sizes expected for monomeric and dimeric complexes containing all seven Mrp proteins. The analyses also revealed a MrpA-to-MrpD sub-complex that could form in the absence of MrpE-to-MrpG but has no antiport activity (22) . Although MrpA and MrpD proteins do not exhibit antiport activity in this sub-complex or when they are expressed individually (10, 23) , one or both of these proteins may have antiport potential. A MrpA/MrpD homologue encoded by a "stand-alone" gene from poly-extremophilic Natranaerobius thermophilus was recently reported to exhibit Na + /H + and K + /H + antiport activity in anaerobically-grown E. coli KNabc (24). MrpA and MrpD are the two largest Mrp subunits. They both have 14 transmembrane segments (TMS) that share homology with each other and with the H + -translocating NuoL, M and N subunits of NADH:quinone oxidoreductases from E. coli or mitochondria (i.e., respiratory chain complex I) (2, 11, (25) (26) . MrpA and its closest Complex I homologue, NuoL, both have a C-terminal extension beyond the core 14 TMS (26). The MrpA and NuoL extensions are not homologous to each other (Fig. S1 ). Except for MrpC, which exhibits some homology to NuoK, none of the other Mrp proteins resembles respiratory chain subunits (17) .
Site-directed mutagenesis studies of B. subtilis Mrp by Kosono and colleagues (19, 27) have identified six acidic residues of MrpA, and one acidic residue in MrpB and MrpD that are required for normal antiport but are apparently not required for Mrp complex formation. The phenotypic effects of mutations observed in E. coli KNabc were consistent with those observed in the native B. subtilis except for one mrpF mutant. However, characterization of B. subtilis Mrp antiport activity by the standard fluorometric assay in E. coli KNabc vesicles (28) is limited by the low activity of B. subtilis Mrp, i.e., there is <20% dequenching of the acridine orange fluorescence, which is the metric used for antiport assessment (19, 27, 29) . Here, we took advantage of the greater activity of the B. pseudofirmus OF4 Mrp system in E. coli KNabc vesicles (>40% dequenching), which facilitates better assessment of antiport deficits of mutant forms and determinations of apparent K m values for Na + . The engineered antiporter construct also made it possible to measure levels of each Mrp protein and visualize the complexes and sub-complexes formed by mutant antiporters. We probed the effects of mutations in twenty-eight different sites throughout the Mrp subunits. The goals were to develop an extensive mutant profile to support or negate the importance of particular motifs in antiport activity, to identify additional residues across Mrp that are required for antiport, and to identify residues that affect membrane levels of other Mrp proteins or formation of one or both of the hetero-oligomeric complexes.
EXPERIMENTAL PROCEDURES
Bacterial strains, plasmids and growth conditions -The bacterial strains and plasmids used in this study are listed in Table S1 . The media for routine growth of E. coli were LB medium (pH 7.0) (30) for strain DH5αMCR and LBK medium plus 50 mM NaCl (pH 7.5) (28) for strain E. coli KNabc (31). Cells were grown with shaking, at 200 rpm, at 37 °C. For growth experiments comparing E. coli transformants expressing wild-type and mutant forms of Mrp for Na + -sensitivity, the strains were grown in LBK, pH 7.5, under the same conditions except that test concentrations between 100-700 mM NaCl were added as indicated in connection with specific experiments. Ampicillin at 100 μg/ml and kanamycin at 25 μg/ml were added to media for plasmid-bearing E. coli KNabc cells and selecting transformants. Transformation of E. coli strains and all recombinant DNA manipulations were carried out by standard methods (30).
Introduction of the site-directed mutations in the mrp operon -pGEMmrpTFCHS7, in which different epitope tags are linked to the carboxyl terminus of MrpA (T7 tag), MrpB (FLAG tag), MrpC (c-myc tag), MrpD (His7 tag), and MrpG (S tag) respectively, was constructed previously (22). In this study, a series of amino acid substituted-mutation plasmids was constructed using pGEMmrpTFCHS7. For introducing site-directed mutagenesis in vitro, The Gene Tailor™ Site-Directed Mutagenesis System (Invitrogen) was used, following the protocols from the instruction manual supplied by Invitrogen. Details of mutant construction are provided in Supplemental Data.
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Preparation of membrane vesicles-E. coli KNabc transformants were grown in LBK medium plus 50 mM NaCl at 37 °C. Everted membrane vesicles were prepared as described previously (22). The membrane vesicles were re-suspended in TCDG buffer (10 mM Tris-HC1, 140 mM choline chloride, 0.5 mM dithiothreitol, and 10% (v/v) glycerol, pH 7.5) for antiporter assays or in ACA buffer (750 mM ε-aminocapoic acid, 50 mM BTP (bis-[tris(hydrozymethyl)-methylamino]-propan e), 20% (w/v) glycerol, pH 7.0) for Blue Native-PAGE analyses. Vesicles were stored at -80 ºC.
Antiport assays -Fluorescence-based assays of the Na + /H + antiport activities were conducted on everted membrane vesicles suspended in TCDG buffer. Protein content was determined using the Lowry method using bovine serum albumin as the protein standard (32). Assays were conducted by the method described by others (9) Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE) -Protein content of the membrane fraction suspended in ACA buffer was determined using the Micro BCA assay (Pierce). Protein complexes (10 mg/ml) were solubilized at 4 °C for 20 min, in ACA buffer containing DDM (dodecyl maltoside) at concentrations of 1.0% (w/v) DDM. Following solubilization, samples were cleared by centrifugation at 40,000 rpm for 90 min in a Beckman Ti70 rotor at 4 °C. The supernatant was divided into 20 μl aliquots which were stored at -80 °C if not used immediately. Protein content was determined using the Micro BCA assay (Pierce). 30 μg of solubilized protein was loaded for BN-PAGE. BN-PAGE was performed in an XCell SureLock™ Mini-Cell using a Native PAGE™ 4-16% gels, 15-well apparatus (Invitrogen). The details of the BN-PAGE protocols were those provided in the instruction manual from Invitrogen. High molecular mass markers, Native Mark™ Unstained Protein Standard, were obtained from Invitrogen. Fig. 1 . The core 14 TMS of MrpA and MrpD differ somewhat from earlier topological predictions by others (31, 35) but are in agreement with the secondary structure revealed by the recent 3-D crystallographic data of Sazanov and the colleagues (26) for the E. coli homologues NuoL, M and N. A piston-like involvement of the MrpA C-terminal extension was hypothesized to energize Mrp antiport in analogy to the proposal for the role of the NuoL C-terminal extension observed in the structure (26). However, the Mrp and Nuo systems may have diverged before development of the piston mechanism since the C-terminal extensions of MrpA and NuoL are distinct and MrpA is lacking in functional Mrp systems from some groups of bacteria, e.g. cyanobacterial Mrp systems (2, 10) .
RESULTS AND DISCUSSION
Multiple alignments of each Mrp subunit from alkaliphile, neutralophile, and pathogens were analyzed by ClustalW software (http://clustalw.ddbj.nig.ac.jp/top-j.html). They are shown in supplemental Fig. S1 . The sequence of NuoL, NuoM, and NuoN, subunits of NADH dehydrogenases from Escherichia coli and Rhodobacter capsulatus, were also aligned with sequences of MrpA and MrpD. Twenty-one highly conserved amino acid residues of the Mrp complex from alkaliphilic B. pseudofirmus OF4 were chosen for inclusion in the mutant panel ( Table 1) . Two of these residues, MrpD F135 and F136, were in a VFF sequence that we identified in MrpD. Kuroda et al (34) reported that a VFF sequence is present in many Na + -coupled transport proteins. They proposed that VFF might be a motif involved in Na + binding. When the phenylalanines of the VFF motif were replaced, there was decreased binding of amiloride, a sodium site probe, to the NhaA antiporter of Vibrio parahaemolyticus while a mutation of valine to leucine had no effect. Including the two MrpD phenylalanines, the full group of highly conserved Mrp residues that were mutated as part of a larger panel was: MrpA-E140, K223, K299, W232 and F405; MrpB-F41, P37 and H34; MrpC-Q70 and T75; MrpD-F135, F136 (the two VFF phenylalanines), E137, K219, and W228; MrpE-T113 and P114 (Table 1 contains data of previously reported mutations in each of these MrpE positions (22)); MrpF-D32, R33 and P28;
and MrpG-P81. Each of these conserved residues was replaced with alanine, except for MrpB-P37 and MrpF-P28, which were replaced by glycine, whose flexibility is closer than that of alanine to proline. More than one replacement was made in several instances. The additional replacements were glycine, threonine and glutamic acid for MrpD-F136, aspartic acid and glutamine for MrpD-E137, tyrosine for MrpE-T113 and glycine for MrpG-P81. The following additional seven residues were chosen for inclusion in the mutant panel for reasons other than conservation alone. MrpA-G392 and MrpC-G82 were included because they correspond to the Mrp residues of alkaliphilic B. halodurans C-125 whose mutations (BH-MrpA-G393R and BH-MrpC-G82E) led to Mrp discovery when they caused loss of alkaliphily (11) (12) . In this study MrpA-G392 from alkaliphilic B. pseudofirmus OF4 was replaced by alanine as well as arginine, while MrpC-G82 was replaced by proline and isoleucine. 
-H-(X) 2/3 -(L/T/S) (35) and Yang et al (A-(X) 3 -H-(X) 2 -S) (36)
. These histidine residues were both replaced by alanine and MrpA-H700 was additionally replaced by lysine and tryptophan. A third histidine residue, MrpA-H230, was also considered a potential quinone binding site because of a report that a histidine residue in the corresponding position of NuoN, NuoN-H224, from E. coli interacts with quinones (37). MrpA-H230 was replaced by both alanine and lysine. Finally, two tyrosine residues in MrpA, MrpA-Y136 and MrpA-Y258, were included in the panel and replaced with alanine because of a suggestion that these tyrosines play a role in Na + movement in homologous respiratory complex subunits (38). Each of the mutations is listed in Table 1 , and their locations are schematically shown on the topological models in Fig. 1 .
Classification of the mutant phenotypes into groups -We classified the mutant phenotypes into eight mutant groups. The mutants of Group 8 had mutations that produced no discernable effects on Mrp or had an effect that did not meet criteria for significance, as indicated below. The following assays were conducted on each mutant and generated the data on which the categorization was based: (i) growth of antiporter-deficient E. coli KNabc transformants at high sodium concentrations; (ii) Figs. S2 and S3) . The MrpA-to-MrpD sub-complex was detected in both mutants (Fig. S5) . The lack of antiport activity is consistent with the earlier conclusion full Mrp complexes are active but the stable MrpA-to-MrpD sub-complex has no antiport activity (22). The MrpE-T113A mutant profile was reported earlier (22), including reduced levels of all the Mrp proteins in the membrane. By contrast the MrpF-D32A mutant exhibited almost normal levels of Mrp proteins except for MrpE and MrpG, which were respectively present at 27% and 42% of wild-type levels. MrpD dimer was present in the antiport-inactive MrpF-D32A mutant, indicating that like the MrpA-to-MrpD sub-complex, the MrpD dimer lacks antiport activity.
Group 2 contains two mutants with mutations in MrpB and MrpC, MrpB-P37G, MrpC-Q70A. The defining feature of this pair of mutants is their effect on only one form of the MrpA-to-MrpG complex. The two Group 2 mutants reproducibly exhibited absence of the monomeric MrpA-to-MrpG complex, while the dimeric complex was detected (Table 1 and Fig. 2). As shown in Fig. 2 , both Group 2 mutants had elevated levels of the MrpA-to-MrpD sub-complex relative to the wild type. They also had elevated amounts of a putative sub-complex composed of MrpE, MrpF and MrpG ( Fig. 2 and  Fig. S6 ). Because of limitations of the MrpE antibody, MrpE protein was detected only by two dimensional Blue native/SDS-PAGE followed by immunoblotting (Fig. S6) Fig. S3 ). Possibly, the monomeric form of the full Mrp hetero-oligomer is present in the mutant membranes but this mutant complex is more unstable upon extraction with detergents than the dimeric hetero-oligomer. Alternatively, the dimeric hetero-oligomeric Mrp complex may account for the vast majority of antiport activity. Group 3 mutants all had very low antiport activity levels. These Mrp systems were unable to support Na + -resistance (Fig. 3 , Table  1 ). These phenotypes may be secondary to reduced membrane levels of all the Mrp proteins, especially MrpE (Table 1 and supplemental Fig.  S4 ). The mutant also had reduced levels of the dimeric Mrp complex and lacked the MrpD dimer whose presence tends to correlate with robust presence of large oligomeric complexes of Mrp (supplemental Fig. S5) (22) . However, complex formation of MrpA-K299A on BN-PAGE was normal as compared with that of wild type. Some members of this group had mutations in charged residues of either MrpA or MrpD. The mutations were MrpA-E140A, MrpA-K223A, MrpA-K299A, MrpD-E137A, MrpD-K219A (Fig. 3) . The MrpA-E140A and MrpD-E137A mutants in homologous positions had been identified as important for antiport of B. subtilis Mrp by Kosono's group (27,39). This study suggests, for the first time, roles in antiport for three conserved lysine residues, MrpA-K233, homologous MrpD-K219, and MrpA-K299. Alanine replacements at all three locations resulted in greatly reduced antiport activity although both hetero-oligomeric Mrp complexes were observed. Like MrpA-E140 and MrpD-E137, the three lysines that are here implicated in antiport roles are conserved 6 among the NuoL, M and N proteins of Complex I as well as across Mrp systems. Mutations in these positions of the respiratory protein homologues have been shown to reduce activity of the proton pumping complex (37,40-41). MrpA-G392R and MrpE-T113Y were also included in Group 3 because of their very low antiport level. They have patterns of Mrp protein and complex contents that are, respectively, similar to MrpA-K223A and MrpD-K219A.
Group 4 contains two mutants, MrpC-G82I and MrpF-R33A. These mutant Mrp systems were able to support Na + tolerance although they had reduced Na + /H + antiport activity. The apparent K m for Na + was not greatly elevated and the membrane levels of Mrp proteins and the complex contents of these mutants were comparable to the wild type pattern.
MrpC-G82I and MrpA-G392R (Group 3) were the site identified original mutation, which led to non-alkaliphilic phenotype in Bacillus halodurans C-125. The MrpC-G82I mutation was in the position corresponding to that of the original B. halodurans C-125 Mrp mutation. This mutation of MrpC-G82 to isoleucine was considered more temperate than the original MrpC-G82E mutation in B. halodurans C-125 (12) . The replacement of MrpC-G82 with isoleucine led to about a 50% loss of antiport activity with retention of the capacity to confer Na + -resistance. There was little reduction in Mrp protein levels and no change in the pattern of complexes and sub-complexes observed in BN-PAGE analyses ( Table 1) . Neither of the two glycines that were mutated in the original B. halodurans C-125 mutagenesis is crucial for antiport inasmuch as the MrpA-G392A and MrpC-G82P mutants of B. pseudofirmus OF4 yielded mutant Mrp systems with no functional phenotype of significance and only a partial reduction in the membrane levels of MrpC itself for the MrpC-G82P mutant (see Group 8) .
Group 5 contains seven mutants whose common feature is a more than 2.5-fold increase in the K m for Na + of the antiport activity (highlighted in blue in Table 1 ). The mutants vary in overall antiport activity level. Unlike the MrpD-E137A mutant in Group 3 that lacked antiport capacity, the conservative replacement in the MrpD-E137D supported almost normal antiport activity levels (Fig. 3) Table 1 ). Finally, Group 5 includes a mutant with an MrpD-F136G mutation that led to reduced Na + -resistance (supplemental Fig. S2 ), reduced antiport levels and elevation of the K m for Na + , without an effect on the levels of Mrp proteins or the profile of complex formation (Table 1) . Other mutations at MrpF-136 and the MrpD-F135A mutation in the putative VFF motif did not affect levels of antiport or any other antiporter properties; these mutants are included in Group 8 ( Table 1) .
Group 6 contains two mutants with single mutations in MrpB and MrpC, MrpB-F41A and MrpC-T75A. The defining feature of this group is a deficiency in growth in the presence of added NaCl even though there is no observable deficit in antiport levels or properties that accounts for the phenotype (Table 1) . One more mutant, MrpD-E137Q, is listed in Group 6 in Table 1 because of its Na + -sensitivity. This mutant is distinct in that the transformant of E. coli KNabc expressing this mutant Mrp grew poorly on LBK medium, even in the absence of added NaCl, and could not be assayed for the parameters shown in Fig.  1 . Perhaps all three of these Group 6 mutants produce a Mrp system that is toxic to the host in some way that increases its sensitivity to Na + , with MrpD-E137Q being an extreme example.
Group 7 contains two mutants in a single residue of MrpG, MrpG-P81, was 7 replaced with either alanine or glycine. These mutants, like the Group 3 mutants and the Group 5 MrpE-P114G mutant, had normal membrane levels of Mrp proteins and normal profiles in BN-PAGE analyses of Mrp complexes and sub-complexes but had very low levels of antiport activity. But unlike those Group 3 mutants, both the MrpG-P81A and MrpG-P81G mutant Mrp systems exhibited an unusual phenotypic feature. The MrpG-P81A and -G mutants retained a wild type Mrp capacity to confer NaCl resistance to cells of Na + /H + antiporter-deficient E. coli KNabc in spite of their very low antiport activity. We also measured intracellular Na + concentrations of the transformants with MrpG-P81G, pGEM7zf(+) vector (negative control), and pGEMmrpTFCHS7 (engineered wild-type Mrp, positive control) in LBK medium with either 100 mM or 300 mM NaCl. The values of the MrpG-P81G transformant were maintained at 17.4±0.7 mM and 41.5±3.8 mM Na + in the medium with 100 mM and 300 mM NaCl, respectively. These values were close to the positive control levels of 16.8±2.0 and 39.2±5.7 while the levels in the negative control transformant were 107.1±7.1 and 196.5±8.8. The phenotype of these mutants raises the possibility that they retain a Na + efflux activity of Mrp that is distinct from Na + /H + antiport. The existence of such additional transport activities of Mrp systems has been hypothesized but none of the activities has yet been biochemically characterized. Alternatively, the mutations at MrpG-P81 may change the catalytic properties of the Mrp complex, conferring a new property that accounts for the capacity to support Na + .
Group 8 contains the remaining mutations:
MrpA-Y136A, MrpA-H230A, MrpA-W232A, MrpA-Y258A, MrpA-H345A, MrpA-G392A, MrpA-F405A, MrpB-H34A, MrpC-G82P, MrpD-F135A, MrpD-F136A, MrpD-F136E, MrpD-F136T, MrpD-W228A, MrpE-P114A, and MrpF-P28G. The phenotype of the mutants in this group was almost identical to that of wild type, except for differences that were assessed as minor in the context of normal levels of antiport activity and capacity to confer Na + -resistance. For example, the amount of MrpC protein observed in membranes of the MrpC-G82P mutant was 43% of the wild-type MrpC subunit level but this mutant was included in the "Normal" group. Residues mutated in Group 8 mutants are presumed not to be essential. Among such residues, is a pair of tryptophan residues in homologous positions of (2, (16) (17) 27 ). The MrpE-to-MrpG module is unique to Mrp systems and is usually encoded by contiguous genes mrpEFG (2) . We hypothesized the MrpE-to-MrpG module is required to induce an antiport-active conformation of the MrpA-to-MrpD module. We also hypothesized that MrpE is required for maintenance of normal membrane levels of other Mrp proteins and to stabilize hetero-oligomeric Mrp complexes. Here, we confirmed the earlier finding that a MrpE-T113A mutant lacked all Mrp complexes except for the MrpA-to-MrpD sub-complex, which had no antiport activity. We further showed that all the Mrp proteins were present in significantly reduced levels in this mutant (Table  1 and supplemental Fig. S4 ). By contrast, a new mutant with a different replacement at this position, MrpE-T113Y, had normal membrane levels of all Mrp complexes and sub-complexes as well as normal levels of each individual Mrp protein. Nonetheless, this mutation led to an antiport activity level <5% of wild-type, which was insufficient to support Na + -resistance. We hypothesize that the threonine  tyrosine change at the 113 position of MrpE prevents the MrpE-to-MrpG module from producing the conformational activation of the MrpA-to-MrpD sub-complex. A similar defect is hypothesized for the MrpE-P114G mutant that exhibited greatly reduced antiport activity together with an increased K m although levels of Mrp proteins and all Mrp complexes were normal; a mutant 8 with an alanine substitution at the same position had no phenotype, underscoring the distinct properties of alanine and glycine in putative TMS regions (Group 8) (Table 1 and supplemental Fig. S3 ). Among the other MrpE-to-MrpG proteins, the MrpG-P81A and G mutants and MrpF-R33A mutation also led to reductions in antiport activity that were particularly severe in the MrpG mutants (Table  1 , Fig. 4 and supplemental Fig. S3 ). These reductions in antiport, as in the MrpE-T113Y and MrpE-P114G mutants, were not correlated with reduced Mrp protein or complex levels (Table 1and supplemental Fig. S3 ). Taken together, the results strongly support a role for the MrpE-to-MrpG module proteins in conferring antiport activity upon Mrp hetero-oligomers.
The mutant panel also revealed that interactions between the MrpA-to-MrpD and MrpE-to-MrpG modules are reciprocal. Among the Group 3 mutants with greatly reduced antiport activity were those with mutations MrpA-E140A, MrpA-K223A and MrpD-137A of the MrpA-to-MrpD module that led to profound reductions in the levels of MrpE as well as reductions in levels of additional Mrp proteins (Table 1 and Sodium/proton antiport activity-1
Complex formation Table 1 . Summary of growth, the anitport activity, membrane expression level , and complex formation of each mutation and positive-and negative-controls.
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